title: Kocuria kristinae infection during adalimumab treatment.
abstract: A common inhabitant of skin, the Kocuria kristinae of the Micrococcaceae family, has gained attention in recent years because it can induce pathology in humans. Reported is a Kocuria kristinae-caused abdominal abscess in a patient treated for rheumatoid arthritis with adalimumab. The tumor necrosis factor (TNF) inhibitor drugs are known to cause various bacterial, viral, and fungal infections. This is the first known case where an opportunistic infection with Kocuria has presented with an abdominal abscess in an immunocompromised individual who is on long term TNF inhibitors.
authors.affiliation: a Department of Neurology , University of Louisville School of Medicine , Louisville , KY , USA.
authors.forename: Murali K
authors.initials: MK
authors.lastname: Kolikonda
authors.affiliation: b Department of Medicine , University of Louisville School of Medicine , Louisville , KY , USA.
authors.forename: Priyanga
authors.initials: P
authors.lastname: Jayakumar
authors.affiliation: c Department of Medicine , New York Medical College , Valhalla , NY , USA.
authors.forename: Srividya
authors.initials: S
authors.lastname: Sriramula
authors.affiliation: d Department of Psychiatry , University of Louisville School of Medicine , Louisville , KY , USA.
authors.forename: Steven
authors.initials: S
authors.lastname: Lippmann
mesh_terms: D018784:Abdominal Abscess / Q000209:etiology / Q000382:microbiology*; D000068879:Adalimumab / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D016908:Gram-Positive Bacterial Infections / Q000209:etiology / Q000382:microbiology*; D006801:Humans; D016867:Immunocompromised Host; D008835:Micrococcaceae; D008875:Middle Aged; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab
keywords: Abdominal abscess; Kocuria kristinae; Micrococcus kristinae; adalimumab; catheter-related infections; rheumatoid arthritis; tumor necrosis factor inhibitor drugs